Login / Signup
Letter: can addition of an immunomodulator really reverse antibody formation and loss of response in patients treated with adalimumab?
K Bendtzen
Casper Steenholdt
Published in:
Alimentary pharmacology & therapeutics (2017)
Keyphrases
</>
rheumatoid arthritis
juvenile idiopathic arthritis
ulcerative colitis
hidradenitis suppurativa
systemic lupus erythematosus